These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 17684183)

  • 21. Selective serotonin reuptake inhibitor usage patterns as risk factors for hospitalization.
    Sheffield RE; Lo Sasso AT; Young CH; Way K
    Adm Policy Ment Health; 2002 Nov; 30(2):121-39. PubMed ID: 12680617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Paroxetine (paxil): use in clinical practice].
    Litvintsev SV; Reznik AM; Arbuzov AL; Mironychev GN
    Voen Med Zh; 2002 Jan; 323(1):35-9. PubMed ID: 11881199
    [No Abstract]   [Full Text] [Related]  

  • 23. Sexual function during bupropion or paroxetine treatment of major depressive disorder.
    Kennedy SH; Fulton KA; Bagby RM; Greene AL; Cohen NL; Rafi-Tari S
    Can J Psychiatry; 2006 Mar; 51(4):234-42. PubMed ID: 16629348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressants and children. Buried data can be hazardous to a company's health.
    Marshall E
    Science; 2004 Jun; 304(5677):1576-7. PubMed ID: 15192185
    [No Abstract]   [Full Text] [Related]  

  • 25. Withdrawal syndromes after paroxetine and sertraline discontinuation.
    Fava GA; Grandi S
    J Clin Psychopharmacol; 1995 Oct; 15(5):374-5. PubMed ID: 8830071
    [No Abstract]   [Full Text] [Related]  

  • 26. Triiodothyronine addition to paroxetine in the treatment of major depressive disorder.
    Appelhof BC; Brouwer JP; van Dyck R; Fliers E; Hoogendijk WJ; Huyser J; Schene AH; Tijssen JG; Wiersinga WM
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6271-6. PubMed ID: 15579788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insomnia moderates outcome of serotonin-selective reuptake inhibitor treatment in depressed youth.
    Emslie GJ; Kennard BD; Mayes TL; Nakonezny PA; Zhu L; Tao R; Hughes C; Croarkin P
    J Child Adolesc Psychopharmacol; 2012 Feb; 22(1):21-8. PubMed ID: 22257126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
    Strawn JR; Mills JA; Croarkin PE
    J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
    [No Abstract]   [Full Text] [Related]  

  • 29. Adolescents with depression.
    Bridge JA; Brent DA
    JAMA; 2004 Dec; 292(21):2578; author reply 2578-9. PubMed ID: 15572710
    [No Abstract]   [Full Text] [Related]  

  • 30. Adolescents with depression.
    Carroll BJ
    JAMA; 2004 Dec; 292(21):2578; author reply 2578-9. PubMed ID: 15572711
    [No Abstract]   [Full Text] [Related]  

  • 31. Adolescents with depression.
    Antonuccio D; Burns D
    JAMA; 2004 Dec; 292(21):2577; author reply 2578-9. PubMed ID: 15572709
    [No Abstract]   [Full Text] [Related]  

  • 32. Adolescents with depression.
    Rifkin A; Rifkin W
    JAMA; 2004 Dec; 292(21):2577-8; author reply 2578-9. PubMed ID: 15572708
    [No Abstract]   [Full Text] [Related]  

  • 33. Nonadherence to paroxetine: a study based on monitoring plasma paroxetine levels.
    Yoshimura R; Ikenouchi-Sugita A; Umene-Nakano W; Hori H; Ueda N; Nakamura J
    J Clin Psychopharmacol; 2010 Feb; 30(1):82-3. PubMed ID: 20075657
    [No Abstract]   [Full Text] [Related]  

  • 34. Sedation corner 11. Fluoxetine.
    Roelofse J
    SADJ; 2006 Jul; 61(6):270. PubMed ID: 16977960
    [No Abstract]   [Full Text] [Related]  

  • 35. Paradoxical reaction to fluoxetine.
    Momen MN; Sebastian CS; Buckley PF
    Psychosomatics; 2003; 44(3):259-60. PubMed ID: 12724510
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of tolerance of venlafaxine, paroxetine and amitriptyline in depression therapy.
    Miskovic M
    Med Arch; 2015 Apr; 69(2):107-9. PubMed ID: 26005260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of adolescents with major depression: contributions of a major trial.
    Glass RM
    JAMA; 2004 Aug; 292(7):861-3. PubMed ID: 15316001
    [No Abstract]   [Full Text] [Related]  

  • 38. Focus on paroxetine.
    Green B
    Curr Med Res Opin; 2003; 19(1):13-21. PubMed ID: 12661775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible serotonin syndrome with trazodone addition to fluoxetine.
    George TP; Godleski LS
    Biol Psychiatry; 1996 Mar; 39(5):384-5. PubMed ID: 8704074
    [No Abstract]   [Full Text] [Related]  

  • 40. Benefits exceed risks of newer antidepressant medications in youth--maybe not.
    Potter WZ
    Clin Pharmacol Ther; 2009 Oct; 86(4):357-9. PubMed ID: 19763114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.